Home » China Shutters Shoddy Drugmakers in Wake of Chromium Capsule Scare
China Shutters Shoddy Drugmakers in Wake of Chromium Capsule Scare
A number of drugmakers in China are being ordered to power down production lines and hand over their licenses for producing capsule-based drugs after a crackdown on chromium contamination by the country’s regulatory agency. Some 13 percent of all drug-capsule makers in China were producing products with excessive, unsafe levels of chromium, China’s State Food and Drug Administration (SFDA) found.
International Pharmaceutical Regulatory Monitor
International Pharmaceutical Regulatory Monitor
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May